GC15962
Belinostat
Also listed as Belinostat (PXD101)
Belinostat (PXD101) is a novel hydroxamate-type inhibitor of histone deacetylase (HDAC) activity in HeLa cell extracts with an IC50 of 27 nM
ChemicalCAS414864-00-9MW318.35FormulaC15H14N2O4S
- CAS number
- 414864-00-9
- Molecular weight
- 318.35
- Formula
- C15H14N2O4S
- Solubility
- ≥ 15·92 mg/mL in DMSO, ≥ 44·1 mg/mL in EtOH with ultrasonic
- InChIKey
- NCNRHFGMJRPRSK-MDZDMXLPSA-N
- Catalogue number
- GC15962
- Brand
- GLPBIO
Computed properties PubChem CID 6918638 · XLogP 1.7 · TPSA 104 Ų · H-bond donors 3
- XLogP
- 1.7
- TPSA
- 104 Ų
- H-bond donors
- 3
- H-bond acceptors
- 5
- Rotatable bonds
- 5
- Heavy atoms
- 22
SMILES C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)/C=C/C(=O)NO
Computed descriptors from PubChem (CID 6918638), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il